Roche sells OTC business to Bayer

Kumar, Rajesh
December 2004
New Zealand Doctor;12/15/2004, p11
Reports on the acquisition of the over-the-counter (OTC) medicines business of Roche by Bayer Healthcare. Cost of the deal; Estimated sales of the combined OTC businesses of Bayer Consumer Care and Roche Consumer Health; Company which was offered to outlicense U.S. non-prescription rights of Roche to Orlistat to GlaxosmithKline


Related Articles

  • Bayer Buys Roche Consumer Division. Houlton, Sarah // Pharmaceutical Executive;Sep2004, Vol. 24 Issue 9, p24 

    Reports on the acquisition of Roche's consumer division by Bayer, a pharmaceutical company. Plan of Bayer to double its over-the-counter drug sales; Increase in consumer health; Reputation of the firms in the drug industry.

  • Bayer: OTC purchase fails to address bigger picture.  // PharmaWatch: Monthly Review;September 2004, Vol. 3 Issue 9, p37 

    Reports on Bayer's acquisition of Roche's over-the-counter (OTC) business. Projected annual sales of the expanded OTC business of Bayer; Speculations on the future of Bayer's overall pharamaceutical business; Problems confronting Bayer's ethical business.

  • Bayer in Exclusive Talks To Acquire Roche's OTC Unit.  // Chemical Market Reporter;7/5/2004, Vol. 266 Issue 1, p6 

    Reports on the negotiation between Bayer AG and Roche Pharmaceuticals for the acquisition of the pharmaceutical company's over-the-counter (OTC) medicines. Significance of the acquisition to the market share of Bayer AG in the OTC drug market; Question on the financing of the deal by Bayer AG;...

  • Bayer to Buy Boots OTC Unit? Scott, Alex // Chemical Week;6/22/2005, Vol. 167 Issue 21, p19 

    Reports on the possible purchase of the over-the-counter (OTC) pharmaceuticals business unit of Boots the Chemists by Bayer. Sales generated by the OTC business in 2004; Expansion plan of Bayer for its HealthCare business; Advantage of the acquisition of OTC business of Roche by Bayer.

  • Bayer's bid wins Roche's otc arm.  // European Chemical News;7/26/2004, Vol. 81 Issue 2110, p9 

    Announces that Bayer won its bid to acquire Roche's over-the-counter (OTC) drugs business in Europe in 2004. Amount paid by Bayer for the acquisition; Purpose of proceeds from the sale; Location of the headquarters of the new Bayer OTC unit.

  • Pharmaceuticals Industry Profile: Taiwan.  // Pharmaceuticals Industry Profile: Taiwan;Dec2005, p1 

    Presents a profile of the Pharmaceuticals industry in Taiwan. Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.

  • Bayer to Buy Roche's OTC Business. Milmo, Sean // Chemical Market Reporter;7/26/2004, Vol. 266 Issue 3, p2 

    Reports that Bayer has agreed to acquire Roche's business in over-the-counter medicines only days after deciding to spin off its Lanxess chemicals operation to shareholders rather than having an initial public offering. Terms of the deal; Plans for the merged business.

  • Bayer set to court Roche's OTC unit. Beacham, Will // European Chemical News;6/14/2004, Vol. 80 Issue 2104, p7 

    Reports on the approval made by Bayer's supervisory board to pursue the bid for Roche's over-the-counter (OTC) drugs business as of June 14, 2004. Companies making it to the second round of bidding; Estimated value of Roche OTC activities; Performance of Bayer's stock.

  • Bayer to Acquire Roche OTC Unit.  // Global Finance;Sep2004, Vol. 18 Issue 8, p51 

    Reports that Germany-based Bayer AG has agreed to buy Roche Consumer Health. Over-the-counter (OTC) drugs business of Switzerland-based pharmaceutical manufacturer Roche Holding; Inclusion in the transaction of Roche's 50% stake in an OTC joint venture in the United States; Countries where Roche...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics